| Plavix, also called “super aspirin”, is manufactured by the Paris-based Sanofi Synthelabo and Bristol-Myers Squibb in the US. Plavix is called a blood thinner, which means that it prevents the formation of platelets in the blood that are responsible for clotting. Plavix is prescribed for atherosclerosis and after angioplasty procedures to prevent the formation of blood clots. The generic name is clopitogrel, and it’s marketed as Isocover outside of the U.S. Plavix was approved by the FDA (Federal Drug Administration) in November 1997.
Suffered harm from Plavix? You may have a lawsuit. Click here, for a top rated law firm to evaluate your legal rights.
The Plavix claim is that it is more effective than aspirin for preventing blood clots, and this claim has made it the second-best-selling drug in the world, with revenues of $6.2 billion. Plavix sells for $4 a pill in the U.S. while aspirin costs only pennies a day.
A recent study financed by Sanofi Synthelabo and released at the March 2006 meeting of the American College of Cardiology calls this claim into question. See Plavix Information and Warnings for more information about the results of the study and the safety of Plavix.
Check out the following articles for more information about Plavix, filing a Plavix lawsuit and finding Plavix attorney.
Suffered harm from Plavix? You may have a lawsuit. Click here, for a top rated law firm to evaluate your legal rights. | 
State Law Center | Legal Links | Site Map | Privacy Policy | Media | About Us | Contact Us